Abstract:The present study was design to examine the effect of tautomerism upon the CoMFA results. Three selected data sets involving protropic tautomerism, which are 21 p-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors, 35 inhibitors of puromycin-sensitive aminopeptidase (PSA), and 67 anxiolytic agents, were used for this purpose. Atom-by-atom alignment technique was adopted to superimpose the molecules in the data sets onto a template. The structural alignments using different tautomeric forms had no significant difference except the atoms involved in tautomerism, which ensures, to a great extent, that the differences of the CoMFA results result primarily from the tautomerism. All-orientation and all-placement search (AOS-APS) based CoMFA models, in addition to the conventional ones, were derived for each system and proved to be capable of yielding much improved statistical results. In the cases of the data sets of HPPD inhibitors and PSA inhibitors, excellent AOS-APS CoMFA models (q2>0.8 with four components for the former and q2>0.7 with seven components for the latter) were obtained, and almost no significant difference in statistical quality was observed when using different tautomeric forms to derive the models. However, it was not the case when treating the data set of anxiolytic agents. The keto tautomer, which was the active form of the PBI type inhibitors, produced measurably better results (q2=0.54 with eight components) than that the enol one (q2=0.37 with five components), indicating the importance of selecting proper tautomer in the CoMFA studies. Furthermore, there existed some substantial differences of the electrostatic field contours between the two different tautomeric forms for all of the three systems considered, whereas the differences in the steric field contour maps were limited. This implies that the resulting new potent ligands may be quite different if one utilizes the CoMFA models of different tautomeric forms for guiding further structural refinements.

Studies of 3D-quantitative structure-activity relationships on a set of nitroaromatic compounds: CoMFA, advanced CoMFA and CoMSIA.

3-D QSAR Study on a Set of Nitroaromatic Compounds

Three-dimensional quantitative structure–activity relationship study for analogues of TQXs using CoMFA and CoMSIA

Three-Dimensional Quantitative Structure−Activity Relationship Analysis of the New Potent Sulfonylureas Using Comparative Molecular Similarity Indices Analysis

Studies on Three-Dimensional Qsar of Muscarinic Receptor Agonists

Three-Dimensional Quantitative Structure-Activity Relationship Analyses of A Series of Butenolide Eta Antagonists

Studies on the 3D-Qsar of Novel 1-Aryl-1, 4-Dihydro-3-acylhydrazinocarbonyl-6-methyl-4-pyridazinones

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

Three-Dimension Quantitative Structure-Activity Relationship Analysis of Some Cinnamamides Using Comparative Molecular Similarity Indices Analysis (CoMSIA)

3D-QSAR Studies on AChE Inhibitory Activities of 2-Phenoxy-indan-1-one Derivatives

Three-dimensional Quantitative Structure–activity Relationship Analyses of a Series of Cinnamamides

Study on the Three-Dimensional Quantitative Structure-Activity Relationship of Pyridazinonyl-Substituted 1,3,4-Thiadiazoles

Three-dimensional Quantitative Structure–activity Relationship Study on Paullones As CDK Inhibitors Using CoMSIA and CoMFA

Recent Progress In Comparative Molecular Field Analysis

Three-dimensional QSAR of HPPD inhibitors, PSA inhibitors, and anxiolytic agents: effect of tautomerism on the CoMFA models.

CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors

2D-Qsar Using Mlr and 3D-Qsar Using Comsia Studies on the Toxicity of Aromatic Hydrocarbons on Larval Sinonvaculina Constricta

Three-dimensional Quantitative Structure Activity Relationship (3D-QSAR) Analysis for in Vitro Toxicity of Chlorophenols to HepG2 Cells.

Study on the Quantitative Structure-Activity Relationship of N-1 Position of Quinolone

Molecular field analysis of two sets of non-peptide corticotropin-releasing hormone antagonists

Improved 3D-QSAR Analyzes for the Predictive Toxicology of Polybrominated Diphenyl Ethers with CoMFA/CoMSIA and DFT.